<DOC>
	<DOCNO>NCT00264355</DOCNO>
	<brief_summary>Following heart transplantation many patient develop acute renal failure early posttransplant phase need renal replacement therapy shorter long time . The cause acute renal failure probably multi factorial many report indicate cyclosporine central role pathophysiology generally recommend low cyclosporine load patient develop acute renal failure population . Several vitro study renal cell culture indicate primary metabolite cyclosporine ( AM1 , AM9 , AM4N ) less toxic kidney cyclosporine . However , secondary metabolite AM19 well cyclic metabolite AM1c AM1c9 associate decreased renal function nephrotoxicity renal transplant recipient . The primary objective pilot study investigate concentration secondary- cyclic metabolite cyclosporine ( AM19 , AM1c , AM1c9 ) relate development acute renal failure early posttransplant phase follow heart transplantation . Secondary objective investigate association genotype P-glycoprotein CYP3A5 metabolic pattern cyclosporine .</brief_summary>
	<brief_title>Metabolic Pattern Cyclosporine A Acute Renal Failure</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Heart transplant recipient receive CsA part immunosuppressive therapy . 18 year age old . Signed informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>cyclosporine</keyword>
	<keyword>metabolite</keyword>
	<keyword>metabolic pattern</keyword>
	<keyword>genotype</keyword>
</DOC>